Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AngioDynamics Down Over 21%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk

AngioDynamics Down Over 21%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk

Dow JonesDow Jones2026/10/08 15:13

AngioDynamics, Inc. (ANGO) is currently at $11.15, down $3.04 or 21.42% --Would be lowest close since June 2, 2026, when it closed at $10.98 --On pace for largest percent decrease since March 30, 2023, when it fell 27.02% --Currently down six of the past seven days --Currently down three consecutive days; down 28.25% over this period --Worst three day stretch since the three days ending Oct. 10, 2022, when it fell 33.27% --Down 27.5% month-to-date --Down 13.16% year-to-date; on pace for worst year since 2023, when it fell 43.06% --Down 64.11% from its all-time closing high of $31.07 on April 28, 2006 --Up 0.09% from 52 weeks ago (Oct. 9, 2025), when it closed at $11.14 --Down 30.87% from its 52-week closing high of $16.13 on Aug. 31, 2026 --Up 14.95% from its 52-week closing low of $9.70 on April 7, 2026 --Traded as low as $11.08; lowest intraday level since June 3, 2026, when it hit $10.90 --Down 21.92% at today's intraday low; largest intraday percent decrease since Jan. 5, 2024, when it fell as much as 26.19% All data as of 11:03:25 AM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 08, 2026 11:13 ET (15:13 GMT)

AngioDynamics, Inc. (ANGO) is currently at $11.15, down $3.04 or 21.42%

--Would be lowest close since June 2, 2026, when it closed at $10.98

--On pace for largest percent decrease since March 30, 2023, when it fell 27.02%

--Currently down six of the past seven days

--Currently down three consecutive days; down 28.25% over this period

--Worst three day stretch since the three days ending Oct. 10, 2022, when it fell 33.27%

--Down 27.5% month-to-date

--Down 13.16% year-to-date; on pace for worst year since 2023, when it fell 43.06%

--Down 64.11% from its all-time closing high of $31.07 on April 28, 2006

--Up 0.09% from 52 weeks ago (Oct. 9, 2025), when it closed at $11.14

--Down 30.87% from its 52-week closing high of $16.13 on Aug. 31, 2026

--Up 14.95% from its 52-week closing low of $9.70 on April 7, 2026

--Traded as low as $11.08; lowest intraday level since June 3, 2026, when it hit $10.90

--Down 21.92% at today's intraday low; largest intraday percent decrease since Jan. 5, 2024, when it fell as much as 26.19%

All data as of 11:03:25 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 08, 2026 11:13 ET (15:13 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny